Zobrazeno 1 - 10
of 23
pro vyhledávání: '"R C, Bethell"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 51:2948-2953
Apricitabine is a novel deoxycytidine analogue reverse transcriptase inhibitor that is under development for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Apricitabine is phosphorylated to its active triphosphate by deoxycyt
Autor:
J. Lippens, C. Ren, P. McKenna, R. F. Rando, B. Allard, N. Nguyen-Ba, R. C. Bethell, J. M. de Muys, Zhengxian Gu, Debra L. Taylor
Publikováno v:
Antimicrobial Agents and Chemotherapy. 50:625-631
SPD754 (AVX754) is a deoxycytidine analogue nucleotide reverse transcriptase inhibitor (NRTI) in clinical development. These studies characterized the in vitro activity of SPD754 against NRTI-resistant human immunodeficiency virus type 1 (HIV-1) and
Autor:
Helen Taylor, R. C. Bethell, Alan J. Wonacott, Anne Cleasby, Andrew R. Whittington, Peter M. Colman, Tadeusz Skarzynski, Jose Varghese, Jan Scicinski, Steven L. Sollis, O.M. Singh, Peter C. Cherry, Paul W. Smith, Neil Taylor, Kevin N. Cobley, Peter D. Howes
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 6:2931-2936
The structure-activity relationships of a series of 4-amino and guanidino-4H-pyran-2-carboxylic acid 6-carboxamides are described. These compounds represent a new class of inhibitor of influenza sialidases and are particularly active against influenz
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 6:1805-1808
N-Propylcarboxamides 1a,b–3a,b have been synthesised from 2,3-didehydro-2,4-dideoxy-4-amino-N-acetylneuraminic acid 4. The tertiary amides 2a,b–3a,b are highly potent but selective inhibitors of influenza A sialidase. The exceptional inhibitory a
Autor:
R. C. Bethell, Andrew R. Whittington
Publikováno v:
Expert Opinion on Therapeutic Patents. 5:793-803
The patent literature on anti-influenza therapies covering the period 1993 to the first half of 1995 is reviewed. The antiviral intervention strategies used to combat influenza A and B are summarised, detailing the current status in each area and new
Autor:
R. C. Bethell, Charon D, Dodic N, Nicholas Cammack, Darren V. S. Green, P. G. Wyatt, Dumaitre B, D. C. Humber, Derek N. Evans, Hopewell Pl
Publikováno v:
Journal of Medicinal Chemistry. 38:1657-1665
A series of benzophenone derivatives has been synthesized and evaluated as inhibitors of HIV-1 reverse transcriptase (RT) and the growth of HIV-1 in MT-4 cells. Through the use of the structure-activity relationships within this series of compounds a
Publikováno v:
J. Chem. Soc., Perkin Trans. 1. :1477-1481
The carbovir triphosphate analogue 10 and its enantiomer 11 have been synthesized and tested as inhibitors of HIV-reverse transcriptase; the enantiomer 11, more remotely resembling natural nucleotides in stereochemical terms, is surprisingly the more
Publikováno v:
Methods in molecular medicine. 24
Viruses that are less sensitive to the influenza neuraminidase (NA)-specific inhibitor 4-guanidino-Neu5Ac2en (zanamavir) (1) can be isolated after several passages in MDCK cells in the presence of the inhibitor. Although there are three reports of a
Publikováno v:
Methods in molecular medicine. 24
The compound 4-guanidino-Neu5Ac2en (zanamivir) has been described as a selective inhibitor of the influenza virus neuraminidase (NA) (1). Viruses that are less sensitive to this inhibitor can be isolated after several passages in MDCK cells in the pr
Autor:
Nicholas Cammack, P McMeekin, B. Patel, D. C. Orr, I. R. Clemens, C L Mo, Duncan S. Holmes, I. L. Paternoster, J Kitchin, R. C. Bethell
Publikováno v:
Journal of Medicinal Chemistry. 36:3129-3136
A series of HIV-1 proteinase inhibitors was synthesized based upon a single penicillin derived thiazolidine moiety. Reaction of the C-4 carboxyl group with (R)-phenylalaninol gave amide 10 which was a moderately potent inhibitor of HIV-1 proteinase (